Ann Surg Oncol (2017) 24:2707–2711 DOI 10.1245/s10434-017-5869-4 O R I G IN AL ARTI CL E – GA STROIN TESTINA L O N C OLO G Y Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Oliver S. Eng, MD, Sinziana Dumitra, MD, MSc, Michael O’Leary, MD, Mark Wakabayashi, MD, Thanh H. Dellinger, MD, Ernest S. Han, MD, Stephen J. Lee, MD, I. Benjamin Paz, MD, Gagandeep Singh, MD, and Byrne Lee, MD Department of Surgery, City of Hope National Medical Center, Duarte, CA ABSTRACT delta base excess of greater than ?4.3 mmol/L at 48 h may Background. Base excess is important in assessing be an appropriate goal for resuscitation of CRS/HIPEC metabolic status. Postoperative management in patients patients in the immediate postoperative period. Standard- undergoing cytoreductive surgery (CRS) with hyperther- ized protocols to correct the base deﬁcit in CRS/HIPEC mic intraperitoneal chemotherapy (HIPEC) for peritoneal patients during the early postoperative period can poten- malignancies can be a challenge, and we therefore sought tially help mitigate perioperative morbidity. to investigate perioperative predictors of overall morbidity in CRS/HIPEC patients at our institution. Cytoreductive surgery (CRS) with hyperthermic Methods. Patients who underwent CRS/HIPEC from 2012 to
Annals of Surgical Oncology – Springer Journals
Published: May 30, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera